Pacira Pharmaceuticals Total Assets:
112.05M for Dec. 31, 2012Pacira Pharmaceuticals Historical Total Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 112.05M |
| Sept. 30, 2012 | 132.83M |
| June 30, 2012 | 142.85M |
| March 31, 2012 | 94.26M |
| Dec. 31, 2011 | 113.49M |
| Sept. 30, 2011 | 77.61M |
| June 30, 2011 | 87.09M |
| March 31, 2011 | 97.87M |
| Dec. 31, 2010 | 66.56M |
| Sept. 30, 2010 | 52.76M |
| June 30, 2010 | 50.24M |
| Dec. 31, 2009 | 43.95M |
About Total Assets
The sum of all current and long-term assets held by a company. An asset is any item with economic value that is held by a company.
Learn More
PCRX Total Assets Benchmarks
| Companies | |
|---|---|
| BioScrip | 642.38M |
| Neurocrine Biosciences | 183.92M |
| Lannett Company | 168.38M |
PCRX Total Assets Rankings
| Overall |
51st percentile 3911 of 8007 |
| Sector |
57th percentile 288 of 685 in Healthcare |
| Industry |
72nd percentile 15 of 54 in Drug Manufacturers - Major |
PCRX Total Assets Range, Past 5 Years
| Minimum | 43.95M | Dec 2009 |
| Maximum | 142.85M | Jun 2012 |
| Average | 89.30M |
PCRX News
Pacira Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 8
Seeking Alpha May 8